University Hospitals of North Midlands has recruited its first patients for the ground-breaking 100,000 Genomes Project.

Fourteen rare disease patients and two cancer patients have now been recruited.

This follows UHNM recently being officially granted ‘Go Live’ status to recruit cancer and rare disease patients to the nationwide project. The aim is to create a new genomic medicine service for the NHS – transforming the way people are cared for both today and in the future. Whilst the project won’t directly cure a patient’s cancer or disease, patients may be offered a diagnosis where there wasn’t one before and in time there is the potential of new and more effective treatments.

UHNM is one of 18 NHS Trusts across the region which have come together to form the West Midlands Genomic Medicine Centre (WMGMC) – one of 13 such collaborations in England which are delivering the programme.

Nationally, the project will sequence 100,000 genomes from around 70,000 people. Participants are NHS patients with a rare disease, plus their families, and patients with cancer.

Dr Christopher Clowes, Genomics Ambassador, said: “The 100,000 Genomes Project is a hugely significant national project, which will hopefully help us discover better ways of treating our patients and in turn help future generations. Progress has been very encouraging so far in terms of recruitment at UHNM, and we are delighted that to date we have 14 people across 5 families for rare diseases and 2 cancer patients. Read more

Similar Posts